Consonance in an amended prospectus today said it would offer 8 million shares at $10 each, down from the original plan for issuing 10 million.
The life sciences SPAC plans to list on the NYSE under CHFW.U. Read more.
Consonance-HFW Lowers IPO by 20% to $80M
